JP2024529315A5 - - Google Patents

Info

Publication number
JP2024529315A5
JP2024529315A5 JP2024500670A JP2024500670A JP2024529315A5 JP 2024529315 A5 JP2024529315 A5 JP 2024529315A5 JP 2024500670 A JP2024500670 A JP 2024500670A JP 2024500670 A JP2024500670 A JP 2024500670A JP 2024529315 A5 JP2024529315 A5 JP 2024529315A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
wound
inhibitor
skin graft
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024500670A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024529315A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/038189 external-priority patent/WO2023009439A1/en
Publication of JP2024529315A publication Critical patent/JP2024529315A/ja
Publication of JP2024529315A5 publication Critical patent/JP2024529315A5/ja
Pending legal-status Critical Current

Links

JP2024500670A 2021-07-30 2022-07-25 皮膚移植方法におけるメカノトランスダクション破壊媒介及びその実施における使用のための組成物 Pending JP2024529315A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163227811P 2021-07-30 2021-07-30
US63/227,811 2021-07-30
US202263340145P 2022-05-10 2022-05-10
US63/340,145 2022-05-10
PCT/US2022/038189 WO2023009439A1 (en) 2021-07-30 2022-07-25 Mechanotransduction disruption mediation in skin grafting methods and compositions for use in practicing the same

Publications (2)

Publication Number Publication Date
JP2024529315A JP2024529315A (ja) 2024-08-06
JP2024529315A5 true JP2024529315A5 (https=) 2025-08-28

Family

ID=85087924

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024500670A Pending JP2024529315A (ja) 2021-07-30 2022-07-25 皮膚移植方法におけるメカノトランスダクション破壊媒介及びその実施における使用のための組成物

Country Status (6)

Country Link
US (1) US20240252494A1 (https=)
EP (1) EP4376907A4 (https=)
JP (1) JP2024529315A (https=)
AU (1) AU2022318736A1 (https=)
CA (1) CA3220398A1 (https=)
WO (1) WO2023009439A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024191790A1 (en) * 2023-03-10 2024-09-19 The Board Of Trustees Of The Leland Stanford Junior University Anti-scarring coated sutures
WO2025064116A1 (en) * 2023-09-18 2025-03-27 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for the treatment of fibrotic conditions and cancer
CN120078753A (zh) * 2023-12-01 2025-06-03 北京生命科技研究院有限公司 茄尼醇在制备预防和/或治疗皮炎的药物中的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012174056A1 (en) * 2011-06-13 2012-12-20 Neumedicines, Inc. Mitigation of cutaneous injury with il-12
US9655967B2 (en) * 2011-12-09 2017-05-23 The Board Of Trustees Of The Leland Stanford Junior University Inhibition of focal adhesion kinase for control of scar tissue formation
US20140072613A1 (en) * 2012-09-10 2014-03-13 Cynthia Lander Compositions and Methods for Treating Cutaneous Scarring
US20170224874A1 (en) * 2014-07-01 2017-08-10 Vicus Therapeutics, Llc Hydrogels for treating and ameliorating wounds and methods for making and using them
WO2019222520A1 (en) * 2018-05-16 2019-11-21 The Board Of Trustees Of The Leland Stanford Junior University Controlled hydrogel delivery of focal adhesion kinase inhibitor for decreased scar formation
CN114401718A (zh) * 2019-07-26 2022-04-26 小利兰·斯坦福大学托管委员会 用于伤口愈合的yap抑制

Similar Documents

Publication Publication Date Title
JP2024529315A5 (https=)
Mutalik Treatment of keloids and hypertrophic scars
Pawlik et al. Co-delivery of ibuprofen and gentamicin from nanoporous anodic titanium dioxide layers
Shanbhag et al. Drug delivery through nails: Present and future
JP2005501883A (ja) セルタコナゾールを含む爪の機能障害および疾患の治療用の膏薬
JP2024123220A5 (https=)
AU2010209455A1 (en) Treatment of psoriasis
JP2004532268A (ja) 異常な角質性物質を除去するための製剤
TW200501934A (en) Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set
JP2024546315A (ja) 三次元生体適合性マトリックスおよび創傷管理におけるその使用
Smith et al. Tissue repair of the epidermis and dermis
US20150216946A1 (en) Composition for reduced scar formation of wounds
CN100435807C (zh) 药物凝胶组合物
JP2011503222A (ja) イオン導入による爪疾患の処置のためのアモロルフィンの使用
US9480828B2 (en) Treatment method for the inferior turbinate
RU2005126492A (ru) Способ местного лечения заболеваний слизистой оболочки полости рта, носа и тканей пародонта при воспалении
JP2009519315A (ja) 皮膚及び粘膜の処置のための製品並びにその調製方法
CN112316108B (zh) 促进及治疗慢性伤口愈合的组合物和方法
JP2006528622A (ja) 軟組織の損傷の処置
JP6453318B2 (ja) 委縮性皮膚瘢痕を治療するためのプロスタグランジンF2α及びその類似体
US11622953B2 (en) Oral composition for the treatment of canker sores
TWI754279B (zh) 用以產生人工痂皮的傷口修復套組
RU2540493C1 (ru) Способ местного лечения красного плоского лишая слизистой оболочки полости рта типичной формы
US9579414B2 (en) Devices and methods for effecting faster healing of orthopedic and other wounds
Kuran et al. The effect of topical phenytoin application on traumatic tympanic membrane perforation